Back to Stories Applied AI

Language Technology for Pharmacovigilance

RISE explores automation of drug safety operations using natural language processing in collaboration with the Swedish Medical Products Agency, studying explainability and efficient on-premise modeling.

January 1, 2024 | State of AI 2024 Report | Page 26–27
Medical documents with text analysis interface
Photograph: GPT-IMAGE-1

We explore automation of drug safety operations involving unstructured data using natural language processing in collaboration with the Swedish Medical Products Agency (Läkemedelsverket).

Research Focus

We study aspects of:

  • Explainability
  • Efficient modeling and training in on-premise settings with sensitive data

Privacy Considerations

Working with sensitive drug safety data requires careful attention to privacy and security. On-premise deployment ensures that sensitive information remains within controlled environments.

Impact

This research enables more efficient processing of drug safety reports while maintaining the transparency and accountability required in regulatory contexts.

Share this story